The American Journal of Managed Care

Outcomes of Liver Transplantation by Insurance Type in the United States

Patients with publicly sponsored insurance who were listed for liver transplantation have worse wait-list and posttransplant outcomes, as shown using the US Scientific Registry of Transplant ...
The American Journal of Managed Care

Glomerular Filtration Rate Change and Outcomes in Type 2 Diabetes

Objectives: To assess the relationship between relative estimated glomerular filtration rate (eGFR) change and outcomes in patients with type 2 diabetes (T2D). Study Design: This retrospective cohort ...
Yahoo Finance

Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP

Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with ...

MoonLake Immunotherapeutics Announces Positive Outcome from Type B Meeting with U.S. FDA and Announces Investor Day

MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical evidence strategy for submission of a Biologic License ...
Nature

Vitamin D and type 2 diabetes: a systematic review

Vitamin D may modify the risk of type 2 diabetes mellitus. The aim of this review was to examine the association between vitamin D status and incident type 2 diabetes, and the effect of vitamin D ...
FierceBiotech

Repros Therapeutics Reports Outcome of Type B Meeting with FDA Regarding Androxal(R) in the Treatment of Secondary Hypogonadism

Repros(R) Therapeutics Reports Outcome of Type B Meeting with FDA Regarding Androxal(R) in the Treatment of Secondary Hypogonadism FDA agrees in general with Androxal development program and ...